当前位置: X-MOL 学术Arthritis Rheumatol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering
Arthritis & Rheumatology ( IF 11.4 ) Pub Date : 2024-05-27 , DOI: 10.1002/art.42923
Clarissa Q Pimentel 1 , Ana Cristina Medeiros-Ribeiro 1 , Andrea Y Shimabuco 1 , Percival D Sampaio-Barros 1 , Júlio César B Moraes 1 , Claudia G Schainberg 1 , Celio Roberto Gonçalves 1 , Elaine P Leon 1 , Léonard De Vinci K Kupa 1 , Sandra G Pasoto 1 , Nádia E Aikawa 2 , Clovis A Silva 2 , Eloisa Bonfa 1 , Carla G S Saad 1
Affiliation  

The aim of this study was to evaluate the influence of anti-infliximab (IFX) antibodies on three different points of care: response/tolerance to IFX, tapering strategy, and in a subsequent treatment with a second tumor necrosis factor inhibitor (TNFi).

中文翻译:


放射学中轴​​型脊柱关节炎患者抗英夫利昔单抗抗体的长期随访:药物存活和逐渐减量的标志



本研究的目的是评估抗英夫利昔单抗 (IFX) 抗体对三个不同护理点的影响:对 IFX 的反应/耐受性、逐渐减量策略以及随后使用第二种肿瘤坏死因子抑制剂 (TNFi) 的治疗。
更新日期:2024-05-27
down
wechat
bug